Alternative Splicing: A Critical Regulator in Human Bone Biology and Tumor Progression

Li Cao(Hubei University of Technology), Wei Wu(Wuhan University of Technology), Jonathan Lee Yang(Washington University in St. Louis), Zengwu Shao(Union Hospital), Brian A. Van Tine(Washington University in St. Louis), Miguel A. Ruiz-Cardozo(Washington University in St. Louis), Ethan Chen(Washington University in St. Louis), Yuxiang Hu(Union Hospital), Ke Jia(North China Electric Power University)
Research
January 1, 2025
10.34133/research.0977
Cited by 2

Related Papers

HSPB1 as a novel regulator of ferroptotic cancer cell death
|Oncogene|2015|673
Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects
|American Journal of Clinical Nutrition|2009|445
Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis
|JAMA|2022|275
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
|Nature Genetics|2017|232
Comparison of the immunological activities of arabinoxylans from wheat bran with alkali and xylanase-aided extraction
|Carbohydrate Polymers|2010|191